NIH study suggests gene variation may shape bladder cancer treatment
Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many pancreatic and prostate tumors, according to research at the National Institutes of Health.
This page was last updated on Friday, January 21, 2022